- The antiaggregatory ASA therapy improves insulin resistance and hyper…
Number of the records: 1  

The antiaggregatory ASA therapy improves insulin resistance and hyperlipoproteinemia in patients with advanced atherosclerosis

  1. The antiaggregatory ASA therapy improves insulin resistance and hyperlipoproteinemia in patients with advanced atherosclerosis / M. Gajdoš, V. Spustová, R. Dzúrik. Ateroskleróza Roč. 1, č. 2 (1997), s. 56
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all